|
CNOT3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.58830000002364E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.037700E-04 |
| Normal-vs-Stage2 |
9.209300E-04 |
| Normal-vs-Stage3 |
1.10250000018297E-07 |
| Normal-vs-Stage4 |
5.99059999999429E-05 |
| Stage1-vs-Stage2 |
8.464200E-01 |
| Stage1-vs-Stage3 |
1.344100E-02 |
| Stage1-vs-Stage4 |
2.802200E-01 |
| Stage2-vs-Stage3 |
1.227030E-01 |
| Stage2-vs-Stage4 |
4.672600E-01 |
| Stage3-vs-Stage4 |
4.577400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.35689999978406E-07 |
| Normal-vs-AfricanAmerican |
4.146500E-02 |
| Normal-vs-Asian |
1.701360E-03 |
| Caucasian-vs-AfricanAmerican |
3.365200E-01 |
| Caucasian-vs-Asian |
3.090200E-01 |
| AfricanAmerican-vs-Asian |
7.281200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.640740E-04 |
| Normal-vs-Female |
1.16530000005E-06 |
| Male-vs-Female |
3.769800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.09029999999055E-05 |
| Normal-vs-Age(41-60Yrs) |
1.55568999999911E-05 |
| Normal-vs-Age(61-80Yrs) |
4.02240000196841E-08 |
| Normal-vs-Age(81-100Yrs) |
5.896400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.429400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.608400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.163800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.696820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.612200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.936800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.28859972376483E-10 |
| Classical-VS-Follicular |
8.129400E-01 |
| Classical-VS-Other |
8.290000E-01 |
| Classical-VS-Normal |
3.92129999999824E-05 |
| Tall-VS-Follicular |
4.90549999998535E-06 |
| Tall-VS-Other |
7.676400E-02 |
| Tall-VS-Normal |
2.32036612146658E-14 |
| Follicular-VS-Other |
8.225000E-01 |
| Follicular-VS-Normal |
1.037590E-03 |
| Other-VS-Normal |
1.539190E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.97460000000472E-05 |
| Normal-vs-N1 |
1.93648999999851E-05 |
| N0-vs-N1 |
2.885200E-01 |
|
|
